WNPRC research led to the first successful Parkinson's gene therapy clinical trial

On March 17, 2011, Lancet Neurology published the report of the first successful randomized, double-blind phase II clinical trial of a gene therapy for Parkinson's or any neurologic disorder. The article cites as groundwork for this trial a 2006 rhesus monkey study led by Marina Emborg, with collaborators from UW-Madison and other institutions.

Emborg is a scientist at the Wisconsin National Primate Research Center (WNPRC) and an assistant professor in the department of Medical Physics at the University of Wisconsin-Madison. An M.D. and Ph.D., she has published numerous scientific journal articles on Parkinson’s disease research, as well as on the ethics associated with translating pre-clinical studies into clinical trials.

Read more on Dr. Emborg's latest research on Parkinson's disease: